Monday, August 31, 2015

Deals

Takeda, Nanotherapeutics expand agreement for commercialization

August 28, 2015 · Leave a Comment 

Takeda Pharmaceutical Company Limited (Takeda), a research-based global company, and Nanotherapeutics, Inc., an integrated biopharmaceutical company, announced an agreement providing Takeda with expanded commercialization and technology access rights related to Nanotherapeutics’ Vero cell technology platform – a cell culture-based platform for vaccine production which Nanotherapeutics acquired from Baxalta, formerly Baxter International’s BioScience division. Financial terms of the agreement were not disclosed. In 2010, Takeda and Baxter entered into an agreement in which Takeda licensed... [Read the full story]

Deal News

Takeda, Nanotherapeutics expand agreement for commercialization

August 28, 2015 · Leave a Comment 

Takeda Pharmaceutical Company Limited (Takeda), a research-based global company, and Nanotherapeutics, Inc., an integrated biopharmaceutical company, announced an agreement providing Takeda with expanded commercialization and technology access rights related to Nanotherapeutics’ Vero cell technology platform – a cell culture-based platform for vaccine production which Nanotherapeutics acquired from Baxalta, formerly Baxter International’s BioScience division. Financial terms of the agreement were not disclosed. In 2010, Takeda and Baxter entered into an agreement in which Takeda licensed... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

INVISTA IPT to Offer Licenses for Green Chem’s FCC Offgas Technology

August 27, 2015 · Leave a Comment 

  WILTON, U.K.–INVISTA’s technology and licensing business — INVISTA Performance Technologies (IPT) — and Beijing Huiersanji Green Chem Co., Ltd. (Green Chem), a Beijing-based technology licensing company, have reached an agreement to enable INVISTA to license Green Chem’s fluid catalytic cracking (FCC) offgas technology outside of China. The process, which will be marketed as DTL™ process technology outside of China, is a dry-gas-to-liquids technology that allows for flexible conversion of light olefins, present in FCC offgas, into either gasoline and distillate or concentrated... [Read the full story]

University Tech Transfer

Allied-Bristol Life Sciences Licenses from Yale University

August 27, 2015 · Leave a Comment 

  BOSTON–Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds (LSE: ALM) and Bristol-Myers Squibb Company (NYSE: BMY), announced that it has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further developed to treat diseases such as prostate cancer, a leading cause of cancer-related deaths among American men. Developed by Professor David A. Spiegel, Ph.D., M.D. and his team at Yale University, the proprietary synthetic molecules, known as... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Takeda, Nanotherapeutics expand agreement for commercialization

Takeda Pharmaceutical Company Limited (Takeda), a research-based global company, and Nanotherapeutics, Inc., an integrated biopharmaceutical company, announced an agreement providing Takeda with expanded commercialization and technology access rights related to Nanotherapeutics’ Vero cell technology platform – a cell culture-based platform for vaccine... Read more of this article


Tessera to Acquire Ziptronix, Inc. for $39 Million

  SAN JOSE, Calif., Aug 27, 2015 — Tessera Technologies, Inc. TSRA, -1.29% (“Tessera” or the “Company”) today announced the acquisition of Ziptronix, Inc. for $39 million in cash. The acquisition expands on Tessera’s existing advanced packaging capabilities by adding a low-temperature wafer bonding technology platform... Read more of this article


Takeda and Nanotherapeutics Announce Agreement

  ALACHUA, Fla. & OSAKA, Japan–Takeda Pharmaceutical Company Limited (Takeda) (TOKYO: 4502) and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and technology access rights related to Nanotherapeutics’ Vero cell technology platform – a cell culture-based platform for vaccine production... Read more of this article


Allied-Bristol Life Sciences Licenses from Yale University

  BOSTON–Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds (LSE: ALM) and Bristol-Myers Squibb Company (NYSE: BMY), announced that it has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further... Read more of this article


Heidelberg Engineering licenses Mass General’s technology

  Heidelberg Engineering (Carlsbad, CA) has entered into a patent license agreement with Massachusetts General Hospital (MGH; Boston, MA), granting global and exclusive rights to 77 basic patents and patent applications relating to swept-source optical coherence tomography (OCT) technology for ophthalmology. Spectral-domain OCT has become indispensable... Read more of this article


INVISTA IPT to Offer Licenses for Green Chem’s FCC Offgas Technology

  WILTON, U.K.–INVISTA’s technology and licensing business — INVISTA Performance Technologies (IPT) — and Beijing Huiersanji Green Chem Co., Ltd. (Green Chem), a Beijing-based technology licensing company, have reached an agreement to enable INVISTA to license Green Chem’s fluid catalytic cracking (FCC) offgas technology outside of... Read more of this article


APG deal helps commercialize NGL technology

  American Power Group Inc. has signed a license agreement with Trident Resources LLC for the exclusive worldwide right to commercialize Trident’s proprietary natural gas liquid (NGL) process technology in the Bakken and other oilfields. APG, a subsidiary of the American Power Group Corp. in Lynnfield, Massachusetts, purchased nearly all... Read more of this article


Lawson and STEMCELL Technologies Announce Partnership

  LONDON, Ontario, Aug. 26, 2015 — Lawson Health Research Institute (Lawson) and STEMCELL Technologies Inc. announced today that they have signed a license agreement giving STEMCELL global exclusive rights to commercialize novel tools for Parkinson’s Disease research. Parkinson’s Disease is the second most common neurodegenerative disorder,... Read more of this article


STEMCELL Technologies Inc. Enters a Licensing Agreement with iPS Academia Japan, Inc.

  VANCOUVER, British Columbia — STEMCELL Technologies Inc. has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.’s patented technologies for induced pluripotent stem cell (iPS cell) research. This agreement will enable STEMCELL Technologies to develop, manufacture, and... Read more of this article


Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

  CARLSBAD, Calif.–Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Allied-Bristol Life Sciences Licenses from Yale University

  BOSTON–Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise... 


Tekcapital Buys Nine Air Conditioning Patents

  LONDON – Technology and intellectual property services company Tekcapital... 


More Posts From University Tech Transfer